ALLIED HEALTHCARE PRODUCTS, INC.: 10-Q filed 2013-02-11

Name: ALLIED HEALTHCARE PRODUCTS, INC.: 10-Q filed 2013-02-11
Creator: ALLIED HEALTHCARE PRODUCTS, INC.

What ALLIED HEALTHCARE PRODUCTS, INC. reported in its quarterly report filed 2013-02-11 (fiscal Q2 2013): 37 published measures, 102 facts as tagged in accession 0001144204-13-007330.

This filing

Form: 10-Q (quarterly report)
Filed: 2013-02-11
Fiscal period: fiscal Q2 2013
Accession: 0001144204-13-007330 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All ALLIED HEALTHCARE PRODUCTS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2012-12-31	30,128,133	USD
At 2012-06-30	31,347,069	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2012-12-31	25,678,436	USD
At 2012-06-30	26,776,685	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2012-12-31	4,586,331	USD
At 2012-06-30	5,284,543	USD
At 2011-12-31	6,251,364	USD
At 2011-06-30	6,512,887	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2012-10-01 to 2012-12-31	-468,693	USD	92
2012-07-01 to 2012-12-31	-879,725	USD	184
2011-10-01 to 2011-12-31	22,690	USD	92
2011-07-01 to 2011-12-31	-122,278	USD	184

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2012-07-01 to 2012-12-31	188,973	USD	184
2011-07-01 to 2011-12-31	651,471	USD	184

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2012-07-01 to 2012-12-31	646,233	USD	184
2011-07-01 to 2011-12-31	912,994	USD	184

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2012-07-01 to 2012-12-31	-240,952	USD	184
2011-07-01 to 2011-12-31	0	USD	184

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2012-07-01 to 2012-12-31	-646,233	USD	184
2011-07-01 to 2011-12-31	-912,994	USD	184

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

Period	Value	Unit	Days
2012-10-01 to 2012-12-31	8,100,593	shares	92
2012-07-01 to 2012-12-31	8,112,490	shares	184
2011-10-01 to 2011-12-31	8,124,386	shares	92
2011-07-01 to 2011-12-31	8,124,386	shares	184

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

Period	Value	Unit	Days
2012-10-01 to 2012-12-31	8,100,593	shares	92
2012-07-01 to 2012-12-31	8,112,490	shares	184
2011-10-01 to 2011-12-31	8,124,834	shares	92
2011-07-01 to 2011-12-31	8,124,386	shares	184

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

Period	Value	Unit	Days
2012-10-01 to 2012-12-31	-0.06	USD/shares	92
2012-07-01 to 2012-12-31	-0.11	USD/shares	184
2011-10-01 to 2011-12-31	0	USD/shares	92
2011-07-01 to 2011-12-31	-0.02	USD/shares	184

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

Period	Value	Unit	Days
2012-10-01 to 2012-12-31	-0.06	USD/shares	92
2012-07-01 to 2012-12-31	-0.11	USD/shares	184
2011-10-01 to 2011-12-31	0	USD/shares	92
2011-07-01 to 2011-12-31	-0.02	USD/shares	184

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

Period	Value	Unit	Days
2012-10-01 to 2012-12-31	-287,263	USD	92
2012-07-01 to 2012-12-31	-539,186	USD	184
2011-10-01 to 2011-12-31	13,907	USD	92
2011-07-01 to 2011-12-31	-74,944	USD	184

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2012-12-31	9,628,935	USD
At 2012-06-30	9,603,556	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2012-07-01 to 2012-12-31	22,428	USD	184
2011-07-01 to 2011-12-31	21,695	USD	184

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2012-10-01 to 2012-12-31	-751,132	USD	92
2012-07-01 to 2012-12-31	-1,410,732	USD	184
2011-10-01 to 2011-12-31	41,043	USD	92
2011-07-01 to 2011-12-31	-187,029	USD	184

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2012-12-31	19,361,290	USD
At 2012-06-30	20,576,081	USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2012-10-01 to 2012-12-31	0	USD	92
2012-07-01 to 2012-12-31	0	USD	184
2011-10-01 to 2011-12-31	0	USD	92
2011-07-01 to 2011-12-31	-336	USD	184

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2012-12-31	4,449,697	USD
At 2012-06-30	4,570,384	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2012-12-31	1,693,881	USD
At 2012-06-30	1,797,144	USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

Period	Value	Unit	Days
At 2012-12-31	3,551,587	USD
At 2012-06-30	4,843,593	USD

Common-stock repurchase payments

Cash paid to reacquire common stock during the period. This is not an authorization limit or a direct measure of the net change in share count.

Period	Value	Unit	Days
2012-07-01 to 2012-12-31	-240,952	USD	184
2011-07-01 to 2011-12-31	0	USD	184

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

Period	Value	Unit	Days
At 2012-12-31	10,049,584	USD
At 2012-06-30	10,001,226	USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

Period	Value	Unit	Days
2012-10-01 to 2012-12-31	2,105,933	USD	92
2012-07-01 to 2012-12-31	4,084,908	USD	184
2011-10-01 to 2011-12-31	2,734,937	USD	92
2011-07-01 to 2011-12-31	5,140,954	USD	184

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

Period	Value	Unit	Days
2012-10-01 to 2012-12-31	2,857,065	USD	92
2012-07-01 to 2012-12-31	5,495,640	USD	184
2011-10-01 to 2011-12-31	2,693,894	USD	92
2011-07-01 to 2011-12-31	5,327,983	USD	184

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2012-12-31	8,030,247	shares
At 2012-06-30	8,124,386	shares

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

Period	Value	Unit	Days
At 2012-12-31	2,016,693	USD
At 2012-06-30	1,136,968	USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

Period	Value	Unit	Days
At 2012-12-31	1,137,908	USD
At 2012-06-30	1,167,432	USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

Period	Value	Unit	Days
At 2012-12-31	1,961,826	USD
At 2012-06-30	1,855,579	USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

Period	Value	Unit	Days
2012-10-01 to 2012-12-31	-755,956	USD	92
2012-07-01 to 2012-12-31	-1,418,911	USD	184
2011-10-01 to 2011-12-31	36,597	USD	92
2011-07-01 to 2011-12-31	-197,222	USD	184

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

Period	Value	Unit	Days
2012-07-01 to 2012-12-31	650,379	USD	184
2011-07-01 to 2011-12-31	627,378	USD	184

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

Period	Value	Unit	Days
2012-10-01 to 2012-12-31	7,645	USD	92
2012-07-01 to 2012-12-31	15,226	USD	184
2011-10-01 to 2011-12-31	11,743	USD	92
2011-07-01 to 2011-12-31	26,149	USD	184

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

Period	Value	Unit	Days
2012-10-01 to 2012-12-31	4,824	USD	92
2012-07-01 to 2012-12-31	8,179	USD	184
2011-10-01 to 2011-12-31	4,446	USD	92
2011-07-01 to 2011-12-31	10,193	USD	184

Deferred income tax expense or benefit

The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.

Period	Value	Unit	Days
2012-07-01 to 2012-12-31	-8,971	USD	184
2011-07-01 to 2011-12-31	-8,678	USD	184

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

Period	Value	Unit	Days
2012-07-01 to 2012-12-31	-1,274,952	USD	184
2011-07-01 to 2011-12-31	-1,138,044	USD	184

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

Period	Value	Unit	Days
2012-07-01 to 2012-12-31	48,358	USD	184
2011-07-01 to 2011-12-31	519,444	USD	184

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

Period	Value	Unit	Days
2012-07-01 to 2012-12-31	-103,263	USD	184
2011-07-01 to 2011-12-31	383,071	USD	184

Inspect the source

Entity: ALLIED HEALTHCARE PRODUCTS, INC. / CIK 0000874710
Captured: 2026-09-22 19:32 UTC
SEC response SHA-256: f694204a453d7f425517aaaf1b9247d581a7c239a0c125906f119959cddf46dc

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000874710.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))